Fortress Biotech

red light green light
Pharma

Sentynl, Cyprium score FDA nod for 1st med for Menkes disease

The FDA has approved Sentynl and Cyprium's Zycubo as the first therapy in the U.S. for the rare genetic neurodegenerative disorder Menkes disease.
Kevin Dunleavy Jan 13, 2026 10:45am
end of the road road block shut down closed blocked
Favicon Fierce Biotech

FDA snubs Fortress' Zydus-partnered Menkes disease candidate

Oct 1, 2025 12:00pm
A close-up view of a jigsaw puzzle with a missing piece
Favicon Fierce Biotech

Novo Holdings-backed biotech raises $205M to fill gout care gap

Sep 30, 2025 8:00am